Patients with NASH have been enrolled in 3 phase III trials of Saroglitazar, says Zydus Cadila Medical Dialogues Bureau18 July 2019 9:17 AM IST"Patients with NASH have been enrolled in these trials across clinical sites in India and Mexico," Cadila Healthcare, the listed entity of the group,...
Zydus Announces Completion of Enrolment in EVIDENCES IV Phase 2 Clinical Trial of Saroglitazar Magnesium in NASH Medical Dialogues Bureau19 Jun 2019 12:01 PM ISTAHMEDABAD: Zydus Cadila, an innovation-driven, global pharmaceutical company, announced that it has completed enrolment of 104 patients with...
Novartis to pay $310 million for assets from inflammation specialist IFM Garima2 April 2019 9:00 AM ISTIFM, whose research head Martin Seidel spent more than a decade at Novartis before assuming R&D duties at IFM in 2017, focuses on immune system...
